JD

Jason Ding

Chief Business Officer

Entos Pharmaceuticals

Toronto, Ontario


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Entos Pharmaceuticals
Industry
biotechnology
Employees
44.0
Seniority
C suite
Annual Revenue
4333000.0
Total Funding
81500000.0
Latest Funding
Other

Technologies

Gmail Google Apps Microsoft Office 365 Amazon AWS Google Tag Manager Mobile Friendly Remote Circle

Keywords

genetic medicine proteolipid vehicles drug delivery redosable nucleic acid payloads nontoxic fusogenix plv fusogenix plv technology genetic medicines nucleic acid delivery precision targeting focus-ai aim technology gene therapy obesity treatment cancer therapeutics stargardt disease rna delivery dna delivery biomanufacturing therapeutic nucleic acids repeat dosing systemic gene therapies non-liver tropic molecular targeting intracellular delivery lipid nanoparticles innovative drug delivery clinical development pharmaceutical partnerships gene editing therapies clinical research clinical trials biopharma immunogenicity obesity & metabolic diseases therapeutic doses biodistribution intravital imaging chronic disease treatments biologics development nanoparticle drug delivery cure genetic diseases revolutionary delivery platform in vivo study healthcare technology next-gen meds metabolic disease programs therapeutic solutions cure diseases drug formulation genetic therapies lipid-based therapies gmp manufacturing ai optimized formulations pharmaceutical industry health care health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans